[Rational therapy with hematopoetic growth factors (G-CSF, GM-CSF) for patients in neutropenia].
Kahl
C
C
Abteilung Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin, Universität Rostock, Germany. christoph.kahl@medizin.uni-rostock.de
Leithäuser
M
M
Freund
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology; D007958:Leukocyte Count; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor